🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 15 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/07/2014 | 31,60 | 31,92 | 30,89 | 31,23 | -2,00% | 3,24% | 294.151 |
| 24/07/2014 | 32,44 | 32,48 | 31,55 | 31,87 | -1,10% | 2,88% | 388.567 |
| 23/07/2014 | 30,76 | 32,48 | 30,76 | 32,22 | +5,11% | 5,60% | 997.868 |
| 22/07/2014 | 32,39 | 32,39 | 30,36 | 30,66 | -4,49% | 6,26% | 1.384.351 |
| 21/07/2014 | 32,02 | 32,43 | 31,36 | 32,10 | +0,25% | 3,33% | 568.744 |
| 18/07/2014 | 31,53 | 32,40 | 31,24 | 32,02 | +1,30% | 3,68% | 801.340 |
| 17/07/2014 | 33,06 | 34,00 | 31,45 | 31,60 | -4,49% | 7,72% | 749.563 |
| 16/07/2014 | 35,63 | 35,79 | 32,83 | 33,09 | -6,70% | 8,30% | 1.417.212 |
| 15/07/2014 | 37,12 | 37,65 | 35,40 | 35,46 | -4,55% | 6,07% | 732.250 |
| 14/07/2014 | 40,06 | 40,06 | 36,94 | 37,16 | -6,50% | 7,79% | 605.934 |
| 11/07/2014 | 39,53 | 40,06 | 39,25 | 39,74 | +0,70% | 2,05% | 276.357 |
| 10/07/2014 | 38,11 | 39,83 | 37,55 | 39,46 | +0,97% | 5,97% | 326.211 |
| 09/07/2014 | 38,39 | 39,67 | 37,82 | 39,08 | +1,87% | 4,81% | 339.996 |
| 08/07/2014 | 39,71 | 39,79 | 37,89 | 38,37 | -3,94% | 4,81% | 655.306 |
| 07/07/2014 | 38,63 | 40,00 | 38,05 | 39,94 | -0,77% | 5,04% | 1.099.498 |
| 03/07/2014 | 40,04 | 40,96 | 39,56 | 40,25 | +1,11% | 3,49% | 315.150 |
| 02/07/2014 | 39,67 | 40,71 | 39,56 | 39,81 | +0,46% | 2,91% | 289.021 |
| 01/07/2014 | 39,05 | 40,21 | 38,61 | 39,63 | +1,97% | 4,09% | 488.594 |
| 30/06/2014 | 38,37 | 39,28 | 37,67 | 38,86 | +0,83% | 4,19% | 632.704 |
| 27/06/2014 | 38,51 | 38,96 | 37,77 | 38,54 | -0,66% | 3,08% | 885.978 |
| 26/06/2014 | 39,12 | 39,30 | 38,43 | 38,80 | -1,14% | 2,20% | 239.969 |
| 25/06/2014 | 38,13 | 39,56 | 37,68 | 39,25 | +3,69% | 4,94% | 449.321 |
| 24/06/2014 | 39,23 | 39,56 | 36,29 | 37,85 | -2,69% | 8,33% | 1.372.168 |
| 23/06/2014 | 41,34 | 41,41 | 38,68 | 38,90 | -5,92% | 6,61% | 642.162 |
| 20/06/2014 | 41,29 | 41,67 | 40,49 | 41,34 | +0,87% | 2,87% | 740.105 |
| 19/06/2014 | 41,20 | 41,34 | 40,15 | 40,99 | +0,11% | 2,89% | 273.312 |
| 18/06/2014 | 39,64 | 41,04 | 39,64 | 40,94 | +2,93% | 3,51% | 353.301 |
| 17/06/2014 | 40,09 | 40,95 | 39,04 | 39,78 | -1,74% | 4,76% | 553.356 |
| 16/06/2014 | 41,96 | 43,57 | 39,47 | 40,48 | -2,79% | 9,77% | 968.853 |
| 13/06/2014 | 41,18 | 42,13 | 40,87 | 41,64 | +0,21% | 3,06% | 241.732 |